Skip to main navigation Skip to search Skip to main content

Acute pancreatitis with long-term celecoxib vs. ibuprofen or naproxen : data from the PRECISION trial

  • Neville D. Yeomans
  • , David Y. Graham
  • , Qiuqing Wang
  • , Kathy Wolski
  • , Jeffrey Borer
  • , M. Elaine Husni
  • , Peter Libby
  • , A. Michael Lincoff
  • , Thomas Lüscher
  • , Lisa M. Wisniewski
  • , Warren Bao
  • , Chris Walker
  • , Steven E. Nissen

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)

Abstract

To the Editor: We read with interest the paper by Hung et al.[1] "Use of celecoxib correlates with increased relative risk of acute pancreatitis: a case-control study in Taiwan". The authors found an odds ratio of 5.6 (95% CI 3.33-9.46) for developing acute pancreatitis in subjects taking celecoxib compared with non-users. Their study was not designed to assess whether the coxib associated with a different risk of pancreatitis than non-selective non-steroidal anti-inflammatory drugs (nsNSAIDs).
Original languageEnglish
Pages (from-to)1053-1054
Number of pages2
JournalAmerican Journal of Gastroenterology
Volume113
DOIs
Publication statusPublished - 2018

Keywords

  • celecoxib
  • pancreatitis

Fingerprint

Dive into the research topics of 'Acute pancreatitis with long-term celecoxib vs. ibuprofen or naproxen : data from the PRECISION trial'. Together they form a unique fingerprint.

Cite this